iifl-logo-icon 1

Blue Jet Healthcare Ltd Share Price

422
(3.83%)
Jul 22, 2024|01:49:56 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open415
  • Day's High426.6
  • 52 Wk High447
  • Prev. Close406.45
  • Day's Low401.05
  • 52 Wk Low319.5
  • Turnover (lac)588.83
  • P/E41.16
  • Face Value2
  • Book Value48.73
  • EPS9.86
  • Mkt. Cap (Cr.)7,320.24
  • Div. Yield0.25
No Records Found

Blue Jet Healthcare Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

415

Prev. Close

406.45

Turnover(Lac.)

588.83

Day's High

426.6

Day's Low

401.05

52 Week's High

447

52 Week's Low

319.5

Book Value

48.73

Face Value

2

Mkt Cap (₹ Cr.)

7,320.24

P/E

41.16

EPS

9.86

Divi. Yield

0.25

Blue Jet Healthcare Ltd Corporate Action

17 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Blue Jet Healthcare Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Blue Jet Healthcare Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:15 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 86.00%

Foreign: 0.00%

Indian: 86.00%

Non-Promoter- 5.04%

Institutions: 5.03%

Non-Institutions: 8.96%

Custodian: 0.00%

Share Price

Blue Jet Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

34.69

34.69

9.91

9.91

Preference Capital

0

0

1.5

0

Reserves

646.79

486.85

329.9

188.3

Net Worth

681.48

521.54

341.31

198.21

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2021Mar-2020

Gross Sales

498.93

538.2

Excise Duty

0

0

Net Sales

498.93

538.2

Other Operating Income

0

0

Other Income

8.88

5.81

Blue Jet Healthcare Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,568.65

123.313,76,323.69867.60.865,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,519.8

76.171,19,994.455310.662,259507.93

Cipla Ltd

CIPLA

1,485.5

32.291,19,928.541,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,144.45

33.511,15,173.541,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,636

25.851,10,759.071,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Blue Jet Healthcare Ltd

Management

Register Office

Registrar Office

Executive Chairman

Akshay Bansarilal Arora:

Managing Director

Shiven Akshay Arora

Executive Director

Naresh Suiyakant Shah

Independent Director

Girish Paman Vanvari

Independent Director

Preeti Mehta

Independent Director

Divya Momaya

Company Sec. & Compli. Officer

Sweta Poddar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited, at Mumbai, dated December 7, 1968. The name of Company was changed to Blue Jet Healthcare Private Limited, and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai. Subsequently, Company got converted into a Public Limited and its name was changed to Blue Jet Healthcare Limited on May 18, 2022. The Company is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. It has operations organized into three product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). It is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products.Since incorporation in 1968, the Company was established with the name Jet Chemicals Private Limited in Shahad (Unit I) by Late Shri B L Arora. It set up a contract development and manufacturing organization (CDMO) business model with specialized chemistry capabilities in contrast media intermediates and high intensity. In 1970, the Company began manufacturing saccharin and its salts, which are high-intensity sweeteners.In 2000, it entered the X-ray contrast media sector, with a basic building block (5- NIPA).In 2002, it started manufacturin
Read More

Company FAQs

What is the Blue Jet Healthcare Ltd share price today?

Down Arrow

The Blue Jet Healthcare Ltd shares price on N/A is Rs.₹419.45 today.

What is the Market Cap of Blue Jet Healthcare Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Blue Jet Healthcare Ltd is ₹7276.01 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Blue Jet Healthcare Ltd?

Down Arrow

The PE and PB ratios of Blue Jet Healthcare Ltd is 41.16 and 8.33 as of 22 Jul ‘24

What is the 52 Week High and Low of Blue Jet Healthcare Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Blue Jet Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Blue Jet Healthcare Ltd is ₹319.4 and ₹446.35 as of 22 Jul ‘24

What is the CAGR of Blue Jet Healthcare Ltd?

Down Arrow

Blue Jet Healthcare Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 2.53%, 6 Month at 8.62%, 3 Month at 3.52% and 1 Month at 1.69%.

What is the shareholding pattern of Blue Jet Healthcare Ltd?

Down Arrow

The shareholding pattern of Blue Jet Healthcare Ltd is as follows:
Promoters - 86.00 %
Institutions - 5.04 %
Public - 8.96 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.